Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty
- PMID: 32960168
- PMCID: PMC7507831
- DOI: 10.1051/sicotj/2020035
Coinfection of HIV and hepatitis C increases complication rates after total joint arthroplasty
Abstract
Introduction: As advances in efficacy of human immunodeficiency virus (HIV) and hepatitis-C virus (HCV) anti-viral medications increase, patients are able to maintain higher quality of lives than ever before. While these patients live longer lives, the unique patient population of those co-infected with both HIV and HCV increases. As these older patients seek orthopaedic care, it is important to understand their unique outcome profile. The purpose of this study was to evaluate the complication rate after total joint arthroplasty (TJA) in patients with HIV and HCV coinfection compared with patients with HIV or HCV only.
Methods: A retrospective review of patients undergoing primary total joint arthroplasty (TJA) at our urban, academic hospital between April 2016 and April 2019 was conducted. Patients were stratified into three groups according to viral status: HIV only, HCV only, or HIV and HCV coinfection. Baseline demographics, intravenous drug (IV) use, surgery type, CD4+ count, follow-up and complications were analysed.
Results: Of the 133 patients included in the study, 28 had HIV, 88 had HCV and 17 were coinfected with both HIV and HCV. Coinfected patients were more likely to have a lower BMI (p < 0.039) and a history of IV drug use (p < 0.018) compared to patients with either HIV or HCV only. Coinfected patients had a higher complication rate (41%) than both HIV only (7%; p < 0.001) and HCV only (12.5%; p < 0.001) patients.
Discussion: Patients coinfected with HIV and HCV undergoing TJA have a higher complication rate than patients with either infection alone. As this unique population of coinfected patients continues to expand, increasingly they will be under the care of arthroplasty surgeons. Improved awareness and understanding of the baseline demographic differences between these patients is paramount. Recognition of the increased complication rates grants the opportunity to improve their orthopaedic care through preoperative and multidisciplinary management.
Keywords: Coinfection; HCV; HIV/AIDS; Total hip arthroplasty; Total joint arthroplasty; Total knee arthroplasty.
© The Authors, published by EDP Sciences, 2020.
Similar articles
-
Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C.Clin Orthop Relat Res. 2018 Feb;476(2):356-369. doi: 10.1007/s11999.0000000000000025. Clin Orthop Relat Res. 2018. PMID: 29529669 Free PMC article.
-
Coinfection with Hepatitis C and HIV Is a Risk Factor for Poor Outcomes After Total Knee Arthroplasty.JB JS Open Access. 2017 Jul 25;2(3):e0009. doi: 10.2106/JBJS.OA.17.00009. eCollection 2017 Sep 28. JB JS Open Access. 2017. PMID: 30229221 Free PMC article.
-
Short and Long-Term Postoperative Complications Following Total Joint Arthroplasty in Patients With Human Immunodeficiency Virus, Hepatitis B, or Hepatitis C.J Arthroplasty. 2018 Jul;33(7S):S86-S92.e1. doi: 10.1016/j.arth.2017.10.061. Epub 2017 Nov 13. J Arthroplasty. 2018. PMID: 29198873
-
Treatment of chronic HCV genotype 1 coinfection.Curr HIV/AIDS Rep. 2015 Sep;12(3):326-35. doi: 10.1007/s11904-015-0278-4. Curr HIV/AIDS Rep. 2015. PMID: 26228050 Review.
-
Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population.Hepatology. 2018 Mar;67(3):847-857. doi: 10.1002/hep.29642. Epub 2018 Jan 30. Hepatology. 2018. PMID: 29108121 Review.
Cited by
-
Complications and surgical treatment after pathological fracture associated to HIV secondary disease. A case report.J Surg Case Rep. 2022 Jun 10;2022(6):rjac223. doi: 10.1093/jscr/rjac223. eCollection 2022 Jun. J Surg Case Rep. 2022. PMID: 35702264 Free PMC article.
-
Total Joint Arthroplasty Should Not Be Delayed in Hepatitis C Patients After Successful Treatment Achieving a Sustained Viral Load.Arthroplast Today. 2022 Aug 29;17:107-113. doi: 10.1016/j.artd.2022.06.014. eCollection 2022 Oct. Arthroplast Today. 2022. PMID: 36082283 Free PMC article.
References
-
- CDC (2013) Monitoring selected national HIV prevention and care objectives by using HIV surveillance data – United States and 6 U.S. dependent areas – 2011. In: HIV Surveillance Supplemental Report.
-
- Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61(1), S45–S57. - PubMed
-
- Mandorfer M, Schwabl P, Steiner S, Reiberger T, Peck-Radosavljevic M (2016) Advances in the management of HIV/HCV coinfection. Hepatol Int 10(3), 424–435. - PubMed
-
- Rosen H (2011) Chronic hepatitis C infection. NEJM 364, 2429–2438. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous